SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 137 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $90,000 | -20.4% | 19,500 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $113,000 | -8.1% | 19,500 | -3.6% | 0.00% | 0.0% |
| Q1 2016 | $123,000 | -25.0% | 20,235 | +12.4% | 0.00% | -50.0% |
| Q4 2015 | $164,000 | +60.8% | 18,000 | 0.0% | 0.00% | +100.0% |
| Q3 2015 | $102,000 | -49.0% | 18,000 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $200,000 | -54.6% | 18,000 | -36.0% | 0.00% | -60.0% |
| Q1 2015 | $441,000 | +60.9% | 28,129 | +56.3% | 0.01% | +66.7% |
| Q4 2014 | $274,000 | -10.2% | 18,000 | -36.4% | 0.00% | -25.0% |
| Q3 2014 | $305,000 | -29.9% | 28,297 | -0.7% | 0.00% | -42.9% |
| Q2 2014 | $435,000 | – | 28,497 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,400,000 | $12,320,000 | 4.56% |
| EcoR1 Capital, LLC | 2,568,119 | $22,599,000 | 4.01% |
| FIC CAPITAL INC | 960,338 | $8,451,000 | 3.48% |
| Opaleye Management Inc. | 580,000 | $5,104,000 | 2.13% |
| DAFNA Capital Management LLC | 225,000 | $1,980,000 | 1.41% |
| RA Capital Management | 1,250,000 | $11,000,000 | 1.26% |
| Iguana Healthcare Management, LLC | 215,000 | $1,892,000 | 1.07% |
| Avoro Capital Advisors LLC | 800,000 | $7,040,000 | 0.89% |
| WASATCH ADVISORS LP | 6,930,535 | $60,989,000 | 0.85% |
| Cormorant Asset Management, LP | 400,000 | $3,520,000 | 0.58% |